Orange Coast Magazine just named our upcoming research conference in the “20 Can’t-Miss Health Events in O.C. To Keep You Healthy!” Don’t miss your chance to attend Trials Today, Treatments Tomorrow, Sept. 21 at the Irvine Marriott. Tickets: http://bit.ly/alzconference or call 949.757.3720 x 3733. “Alzheimer’s affects more than 84,000 people in Orange County. This conference, hosted by the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND) and Alzheimer’s Orange County, will bring world-renowned experts to Irvine to discuss progress in the battle against Alzheimer’s.” — Orange Coast Magazine
Contributed by Joshua Grill, PhD This week’s 60 Minutes did an excellent job of illustrating, in 13 minutes, the 10-year progression of Alzheimer’s disease and its impact on patients and their caregivers. In addition to the unrelenting progression of the disease, the piece showed viewers the toll the disease takes on care providers, including the physical, financial, and emotional burdens. On average, the cost of caring for a person with Alzheimer’s disease is estimated to exceed $300,000 total. And caregivers are at increased risk for physical and mental ailments, resulting from the stress of their role and the fact that…
UCI MIND Director Dr. Joshua Grill wrote an article for the Daily Pilot about the need for Alzheimer’s clinical trial research participants in Orange County. Read an excerpt below, and click here for the full article > “Here in Orange County, we are home to the Alzheimer’s Disease Research Center, the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND). And we are making progress. There will be one essential key to needed advances, however. You. We need more people to participate in research, especially clinical trials of promising treatments. Clinical trial participants in Alzheimer’s research, much like…
The New York Times recently covered a new clinical trial effort Eli Lilly is undertaking, the TRAILBLAZER-ALZ clinical research study. The study, which UCI MIND investigators are participating in, aims to enroll 375 people with early Alzheimer’s disease. To learn more about the TRAILBLAZER-ALZ study, click here, or contact us at email@example.com or call 949.824.0008.
UCI MIND is proud to partner with Maria Shriver’s Women’s Alzheimer’s Movement in researching why women are more likely than men to develop Alzheimer’s disease. The LA Times recently covered this partnership and the UCI researchers who were awarded grants to study gender differences. For more, read the article found in the Daily Pilot>
Dr. Jeffrey Cummings, the inventor of the Neuropsychiatric Inventory and international leader in the field of Alzheimer’s disease clinical trials was awarded the Bengt Winblad Lifetime Achievement Award at the Alzheimer’s Association International Conference. To hear Dr. Cummings lecture about the state of Alzheimer’s disease clinical trials, register for the UCI MIND Southern California Alzheimer’s Disease Research Conference at bit.ly/alzconference
Professors Andrea Tenner (seen here, middle) and Frank LaFerla, along with other members of UCI MIND’s Next Generation Animal Models grant presented their work at the Accelerating Medicines Partnership—Alzheimer’s Disease (AMP-AD) meeting at a pre-conference to the Alzheimer’s Association International Conference in Chicago on July 19 and 20.